speb/financial-data huggingface dataset:
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 221965000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 597067000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 597067000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 8125000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2506596000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 2434000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Net Debt: 2131544000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 2192000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income: 427458000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 427458000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 429735000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 427458000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 427458000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 582759000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 429736000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Interest Income: -213534000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -16749000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -150899000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 0.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -213534000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 1000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2157969000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -260046000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -150899000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2490246000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 54011000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8125000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 32566000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 915776000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Normalized Income: 410471590.14
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 698889000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Operating Income: 674685000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 9398165000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 70697560.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 2000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 415726000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 12761000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 2279722000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 73228000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 33930000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 213671000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 32522000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -2434000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 11014000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 264358000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Payable: 12692000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 82410000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 54632000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 17761000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Other Special Charges: -22401000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Payables: 1203332000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 4437000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 153802000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Pretax Income: 582605000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -307683000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 447022000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 7202368000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 152659000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -150899000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Research And Development: 10361000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 166794000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 1957894000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 47637000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 347533000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 471768000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 70697560.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 0.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -150899000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Special Income Charges: 22399000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2646765000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2490246000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 6042590.14
INDOAMIN.NS income_statement (annual, 2024-03-31) — Tax Provision: 152870000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 211188000.00
INDOAMIN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -145437000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 6347627000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 3243832000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2169859000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2649199000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Total Expenses: 8723480000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3698428000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2386486000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 663223000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 19093000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 18805000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 23029000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 1175420000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Work In Process: 220209000.00
INDOAMIN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 925933000.00
INDOAMIN.NS income_statement (annual, 2024-03-31) — Write Off: 2000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2509483000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 49813000.00
INDOAMIN.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 72219372.00
INDOAMIN.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 1.91
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 353488000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 79128000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 320292000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 353488000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 2929977000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 400880000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4704545000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 2054628000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2054628000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2508959000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 14256000.00
INDOAMIN.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 72219372.00
INDOAMIN.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 1.91
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 146557000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2407946000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1373617000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 5599805000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 49813000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 615200000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 615200000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 22912000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 2226000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2590700000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2407946000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 2783420000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 58124000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 70697560.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 498605000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 404184000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 2576489000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 63266000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 32517000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1000000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2007066000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 2548000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 241164000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 35891000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 70697560.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 2929977000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 2783420000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 7341378000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 3545177000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2669828000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 2932203000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4409175000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 2636833000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1900216000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 35891000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Tradeand Other Payables Non Current: 1186180000.00
INDOAMIN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 2195586000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 663306000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 2588448000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 74424342.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.52
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 1724347000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 43376000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 43376000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 74424342.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.52
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — EBIT: 224744000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — EBITDA: 268120000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 864101000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 57024000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 57024000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -57024000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -57024000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 268120000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 113125000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Operating Income: 200795000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 2588448000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 23949000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 483777000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 167720000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1724347000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 43376000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 54595000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.33
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 2387653000.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 2636259000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 695583000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 10786786000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2854149000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1275736000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1275736000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2662029000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2662029000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1496511000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 292487000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 54146000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 54146000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 72591429.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 70542262.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Basic EPS: 7.70
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.68
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 205109000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 781208000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -913831000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 27177000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 27177000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 43461000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 43461000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -35349000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 257458000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -170624000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 118252000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Payable: 98965000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -484063000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -596200000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -53605000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 362938000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -35349000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 3169892000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3176271000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 350857000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 350857000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 7310331000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1952249000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4705302000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4705303000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Current Debt: 2057849000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 2057849000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 2057849000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2057849000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 14919000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3723195000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3723195000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 296389000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 296389000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Depreciation: 170420000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 170420000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 170420000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 41791000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 170420000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 41791000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 72591429.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 70542262.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 7.70
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.68
INDOAMIN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 118511000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 9630000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 462000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — EBIT: 992490000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — EBIT: 209146000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — EBITDA: 1162910000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 250937000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 151505000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 415976000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 551125000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -477806000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: 251000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 713000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 139825000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 139825000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 2857451000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 4353962000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Gross Profit: 3476455000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 901900000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 5000000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Interest Expense: 223041000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 56694000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 223041000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 56694000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Interest Income: 10415000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 10415000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -223041000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 10415000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Inventory: 1398139000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1398139000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 6020496000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6014117000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -823605000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 12399000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 54146000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 288212000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 288212000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 786376000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 786376000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 786376000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 786376000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 9608000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 9608000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 2838946000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 6464000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 6464000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Minority Interests: -6464000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2817048000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2817048000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 6843000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income: 118511000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 118511000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 558952000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 118510000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 118511000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 118511000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 769279000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 118511000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Interest Income: -223041000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -56694000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -5215000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 674366000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 189309000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -223041000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -56694000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2857451000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2857451000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -829266000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 189309000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3030067000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3030067000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 71272000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 71272000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 9608000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 9608000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 41747000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 41747000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1162910000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 250937000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Normalized Income: 558954000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 118511000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 354024000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Operating Income: 840196000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 206317000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 10786786000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2854149000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 72587560.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 72587560.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 473559000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 473559000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 353908000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 353908000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 2806954000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 2806954000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 56534000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 56536000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 212796000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 30732000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 30732000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 1000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 152294000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2828000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1910088000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 504142000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Payable: 15317000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 15317000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2506594000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2506594000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 134374000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3785000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 140613000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 16284000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Payables: 1311735000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1290655000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 155397000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 155397000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Pretax Income: 769449000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 152452000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -831830000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 543853000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 543853000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 7310331000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1952249000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 170420000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 41791000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 124329000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2481410000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 2564000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 499664000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Share Issued: 72587560.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 72587560.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 3176271000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3176271000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3030067000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3036444000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Tax Provision: 210497000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 33942000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.27
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.22
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 301954000.00
INDOAMIN.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -193939000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7787454000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7787454000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 3956268000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3956268000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2844225000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2844225000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 3176356000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3176356000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Total Expenses: 9946590000.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2647832000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4604719000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4611098000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3082156000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3082154000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 881524000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 887903000.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 14919000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 14919000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS balance_sheet (annual, 2025-03-31) — Working Capital: 982107000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 982107000.00
INDOAMIN.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 689183000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2875853000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 73200761.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 3.94
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1924333000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 50795000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 50795000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 73200761.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 3.94
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — EBIT: 417549000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — EBITDA: 468344000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 951520000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 62000000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 62000000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 288412000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -62000000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -62000000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 468344000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 288411000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Operating Income: 262337000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2875853000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 155212000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 486349000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 355549000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1924333000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 50795000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 67137000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2613516000.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 696191000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2770451000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1225506000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2622478000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 58770000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 72442800.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 2.50
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 55693000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 74260000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 362938000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3602318000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 652645000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1806852000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4957346000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2252680000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2252680000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3912613000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 28581000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 52274000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 52274000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 72442800.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 2.50
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — EBIT: 316464000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — EBITDA: 368738000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 83291000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 132439000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3201216000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 963599000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 60569000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 60569000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1676993000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6671727000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 58770000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 816729000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 816729000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 13518000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 6598000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 3013716000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -60569000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -60569000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3201216000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3469879000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 78414000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 368738000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 181107000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Operating Income: 267408000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2770451000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 72587560.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 430656000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 367015000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 3239380000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 49148000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 84385000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 49056000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 484845000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2548571000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3251000.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 18567000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
INDOAMIN.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1264337000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 255895000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1806852000.00
INDOAMIN.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 52274000.00